文献速递胃肠外科围术期管理与 ERAS

内镜治疗与胃切除术治疗早期食管胃结合部腺癌的远期结局相当:一项基于人群的研究

Comparable long-term outcomes after endoscopic therapy and gastrectomy of early adenocarcinoma of esophagogastric junction: a population-based study.
PubMed 文献 · Surg Endosc · 2022-03-29

该回顾性队列研究利用SEER数据库2004–2017年数据,纳入881例接受内镜治疗或胃切除术的早期食管胃结合部腺癌患者,其中内镜治疗227例(36.2%)、胃切除术654例(63.8%)。多因素Cox回归和竞争风险模型均显示两组癌症特异性生存风险相似,倾向性评分匹配后结果一致,提示内镜治疗在这些患者中具有支持作用。

要点

  • 早期AEGJ患者接受内镜治疗与胃切除术的癌症特异性生存风险相似。
  • 多因素Cox回归HR 0.93(95%CI 0.55-1.56,P=0.78),竞争风险模型SHR 0.86(95%CI 0.50-1.45,P=0.56)。
  • 倾向性评分匹配后(各210例),Cox回归HR 0.97(95%CI 0.53-1.77,P=0.92),竞争风险模型SHR 0.96(95%CI 0.52-1.77,P=0.89)。

核心结论

  • 早期AEGJ患者接受内镜治疗或胃切除术的远期结局相当,支持内镜治疗在这些患者治疗中的作用。

研究设计与样本

  • 回顾性队列研究,使用监测、流行病学和最终结果(SEER)数据库2004–2017年数据,纳入881例接受内镜治疗或胃切除术的早期AEGJ患者。

主要发现

  • 881例早期AEGJ患者中,227例(36.2%)接受内镜治疗,654例(63.8%)接受胃切除术。
  • 多因素Cox回归显示内镜治疗组与胃切除术组癌症特异性死亡风险相似(HR 0.93;95%CI 0.55-1.56;P=0.78)。
  • 多因素竞争风险模型显示内镜治疗组与胃切除术组癌症特异性死亡风险相似(SHR 0.86;95%CI 0.50-1.45;P=0.56)。
  • 倾向性评分匹配后,210例内镜治疗患者与210例胃切除术患者匹配,多因素Cox回归显示癌症特异性死亡风险相似(HR 0.97;95%CI 0.53-1.77;P=0.92)。
  • 倾向性评分匹配后,多因素竞争风险模型显示癌症特异性死亡风险相似(SHR 0.96;95%CI 0.52-1.77;P=0.89)。

临床怎么用

  • 对于早期AEGJ患者,内镜治疗可作为胃切除术的考虑选项之一,但需结合患者具体情况选择。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Current guidelines recommend consideration of endoscopic therapy (ET) when treating selected early gastric cancers. However, clinical decision-making on ET versus gastrectomy for early adenocarcinoma of esophagogastric junction (AEGJ) remains challenging because of uncertain long-term outcomes. METHODS: We performed a retrospective cohort study using the Surveillance, Epidemiology, and End Results database from 2004 to 2017 of early AEGJ patients underwent ET or gastrectomy. Multivariate models were used to compare cancer-specific survival (CSS). RESULTS: Of 881 included early AEGJ patients, 227 (36.2%) patients underwent ET and 654 (63.8%) patients underwent gastrectomy. Early AEGJ patients who underwent ET experienced a similar hazard of cancer-specific death compared with those underwent gastrectomy in both multivariate Cox regression (HR [hazard ratio], 0.93; 95% CI [confidence interval], 0.55-1.56; P = 0.78) and the multivariate competing risk model (subdistribution HR [SHR], 0.86; 95% CI 0.50-1.45; P = 0.56). Propensity score matching was used, 210 patients underwent ET were matched with 210 patients underwent gastrectomy. Patients underwent ET experienced a similar hazard of cancer-specific death compared with those underwent gastrectomy in both multivariate Cox regression (HR, 0.97; 95% CI 0.53-1.77; P = 0.92) and the multivariate competing risk model (SHR, 0.96; 95% CI 0.52-1.77; P = 0.89). CONCLUSION: Early AEGJ patients who received ET or gastrectomy had comparable long-term outcomes, which lend support to the role of ET in the treatment of these patients.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. GuoHui M, MingHua Z, ZhenYu C, et al. Comparable long-term outcomes after endoscopic therapy and gastrectomy of early adenocarcinoma of esophagogastric junction: a population-based study. Surg Endosc. 2022. PMID: 35352149. doi:10.1007/s00464-022-09187-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。